Abstract
Purpose
The evidence regarding association between thyroid disorders and benign and malignant breast diseases is increasing. The studies exploring the relationship between thyroid and breast diseases usually have focused on thyroid autoimmunity and functions in patients with breast pathologies. In this study, we aimed to reveal the frequency of benign breast conditions in patients with nodular thyroid disease (NTD) and Hashimoto’s thyroiditis (HT).
Methods
Seventy-one women with NTD, ninety-five women with HT and seventy-two healthy people as a control group were included in the study. Serum thyroid-stimulating hormone, free triiodothyronine, free thyroxine, and thyroid peroxidase autoantibody levels were measured, and thyroid and breast ultrasonography were performed by a single operator in order to determine thyroid and breast pathology.
Results
Benign breast diseases were detected in 54.9 % of patients with NTD, in 47.4 % of those with HT, and 29.2 % of control group in the study (p < 0.01 for nodular and Hashimoto groups versus control group). Simple cyst was found to be the most frequent pathology among benign breast diseases; fibrocystic changes, mixed lesions, benign solid mass, ductal ectasia, and complex cyst followed it. No significant relation was found regarding thyroid function and autoimmunity in patients diagnosed with benign breast disease (p > 0.05).
Conclusions
The results of our study support the association between benign breast diseases and thyroid diseases. An important implication of this finding may be demonstration of the necessity of scanning for potential breast pathology in women with nodular or autoimmune thyroid disease in clinical practice.
Similar content being viewed by others
References
Salvatore D, Davies TF, Schlumberger MJ et al (2011) Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology, 12th edn. Elsevier Saunders, Philadelphia, pp 327–478
Adamopoulos DA, Vassilaros S, Kapolla N et al (1986) Thyroid disease in patients with benign and malignant mastopathy. Cancer 57:125–128
Giustarini E, Pinchera A, Fierabracci P et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154:645–649
Vassilopoulou-Sellin R, Palmer L, Taylor S et al (1999) Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696–705
Saraiva PP, Figueiredo NB, Padovani CR et al (2005) Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38:761–765
Brunn J, Block U, Ruf G et al (1981) Volumetric Analysis of Thyroid Lobes by Realtime Ultrasound. Dtsch Med Wochenschr 106:1338–1340
Mehta T (2003) Current uses of ultrasound in the evaluation of breast. Radiol Clin North Am 41:841–856
Baskin B, Hadar O, Tashman S et al (2005) Sonographic diagnosis of breast cancer. In: Roses DF (ed) Breast Cancer, 2nd edn. Elsevier Churchill Livingstone, Philadelphia, pp 247–269
Giani C, Fierabracci P, Bonacci R et al (1996) Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81:990–994
Smyth PPA, Shering SG, Kilbane MT et al (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711–2716
Macfarlane IA, Robinson EL, Bush H et al (1980) Thyroid function in patients with benign and malignant breast disease. Br J Cancer 41:478–480
Bhargav PRK, Mishra A, Agarwal G et al (2009) Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 33:2087–2093
Prinzi N, Baldini E, Sorrenti S et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3921 patients. Breast Cancer Res Treat 144(3):683–688
Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177
Tosovic A, Becker C, Bondeson AG et al (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131(9):2126–2133
Muller I, Pinchera A, Fiore E et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352
Nio Y, Iguchi C, Itakura M et al (2009) High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders. Anticancer Res 29(5):1607–1610
Farahati J, Roggenbuck D, Gilman E et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714
Ditsch N, Mayr D, Lenhard M et al (2012) Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma. Oncol Lett 4(4):665–671
Ditsch N, Toth B, Himsl I et al (2013) Thyroid hormone receptor (TR) alpha and TR beta expression in breast cancer. Histol Histopathol 28(2):227–237
Govindaraj V, Yaduvanshi NS, Krishnamachar H et al (2012) Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues. Horm Mol Biol Clin Investig 9(3):173–178
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anil, C., Guney, T. & Gursoy, A. The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis. J Endocrinol Invest 38, 971–975 (2015). https://doi.org/10.1007/s40618-015-0269-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-015-0269-8